Macrogol: Evaluation of the perception of effectiveness and quality of life in individuals with constipation

Authors

  • Nuno Correia Sanofi, Lisboa
  • Francisco Guarner Consultor de Gastroenterología, Barcelona, Spain https://orcid.org/0000-0002-4051-0836
  • Georgina Logusso Sanofi, Barcelona

DOI:

https://doi.org/10.30827/ars.v63i3.24409

Keywords:

constipation, quality of life, macrogol, effectiveness perception surveys

Abstract

Introduction: Constipation has a prevalence of 14-30% in Spain, its cause is multifactorial and negatively affects people’s well-being and quality of life. Treatments for functional constipation include osmotic laxatives such as Macrogol 4000. The degree of satisfaction with laxatives is proportional to the perceived effectiveness and improvement in quality of life.

Method: a survey was conducted in Spanish pharmacies among 100 consumers who purchased Macrogol 4000 as a medical device, in order to treat the symptoms of constipation. Changes in quality of life and subjective perception of effectiveness were measured after 4, 8 and 14 days of treatment using CATI methodology, based on telephone surveys.

Results: After 14 days of consumption, a significant reduction (p<0.05) in physical and psychosocial discomfort was observed. Responses on the effectiveness perception questionnaires improved after day 8. The number of responses expressing agreement with subjective perceptions of relief from constipation (81%-97%), of well-being (90%-96%) and of improved physical sensations (77%-97%) increased. At the end of the study, 95% of participants were satisfied or very satisfied with the chosen treatment.

Conclusions: The use of Macrogol 4000 for 14 days improves physical and psychosocial discomfort at the same time as there is an increase in the perception of its effectiveness in individuals with functional constipation.

Downloads

Download data is not yet available.

References

Garrigues V, Gálvez C, Ortiz V, Ponce M, Nos P, Ponce J. Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain. Am J Epidemiol. 2004;159:520-6. Doi: 10.1093/aje/kwh072

Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750-9. Doi: 10.1111/j.1572-0241.2004.04114.x

Serra J, Mascort-Roca J, Marzo-Castillejo M, Delgado Aros S et al. Guía de práctica clínica sobre el manejo del estreñimiento crónico en el paciente adulto. Parte 2: Diagnóstico y tratamiento. Gastroenterol Hepatol. 2016; Doi: 10.1016/j.gastrohep.2016.02.007

Tack J, Müller-Lissner S. Treatment of chronic constipation: Current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol. 2009;7:502-8.

Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, KnottnerusA. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380-2. Doi: 10.1016/j.jclinepi.2010.09.011

Guyatt G, Oxman AD, Akl E, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profilesand summary of findings tables. J Clin Epidemiol. 2011;64:383-94. Doi: 10.1016/j.jclinepi.2010.04.026

Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G,et al. GRADE guidelines: 2. Framing the question and decidingon important outcomes. J Clin Epidemiol. 2011;64:395-400. Doi: 10.1016/j.jclinepi.2010.09.012

Belsey J, Greenfield D, Candy D et al. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther. 2010; 31, 938–949. Doi:10.1111/j.1365-2036.2010.04273.x.

Marquis P, De La LC, Dubois D, McDermott, A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 2005; 40:540–51. Doi: 10.1080/00365520510012208

Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007;25:599--608. Doi: 10.1111/j.1365-2036.2006.03238.x

Mearin F. Impacto del estreñimiento crónico en la calidad de vida: mucho más importante de lo que parece. Gastroenterol Hepatol. 2013;36(7):467-472. Doi: 10.1016/j.gastrohep.2012.11.009

Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835-40.

Ruta DA, Garrant AM, Leng M, Rusell IT, MacDonald LM. A new approach to the measurement of quality of life. The patient generated Index. Med Care. 1994;11:1109–26. Doi: 10.1097/00005650-199411000-00004

Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997;32:1083-9. Doi: 10.3109/00365529709002985

López-Roldán P, Fachelli S, Metodología de la investigación social cuantitativa.1ª Edición: http:/ /ddd.uab.cat/record/129382 ; 2015.35p

Published

2022-06-22

How to Cite

1.
Correia N, Guarner F, Logusso G. Macrogol: Evaluation of the perception of effectiveness and quality of life in individuals with constipation. Ars Pharm [Internet]. 2022 Jun. 22 [cited 2024 Jul. 22];63(3):234-43. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/24409

Issue

Section

Original Articles